<p>Derek J. Maetzold, President and Chief Executive Officer of Castle Biosciences Inc., reported a disposal of common shares of the company, according to a recent SEC filing. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Castle Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-003089), on January 22, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here</p>

IDNA

Reuters

iShares Genomics Immunology and Healthcare ETF

Invesco Biotechnology & Genome ETF

iShares US Healthcare Providers

First Trust NYSE Arca Biotech Index Fd

VanEck Biotech ETF

ALPS Medical Breakthrough

iShares Biotechnology ETF

iShares US Medical Devices

SPDR S&P Biotech

Castle Biosciences

Health Care Select Sector SPDR

Ark Genomic Revolution ETF

Proshares Ultra Nasdaq Biotech

Castle Biosciences CEO Derek J. Maetzold Reports Sale of Common Shares